Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Gruvaktiebolaget Viscaria | VISC | Nov 15, 2024 | 23.30 | +0.65 |
Gränges | GRNG | Nov 15, 2024 | 126.80 | 0.00 |
Grängesberg Exploration Holding | GRANGX | Nov 15, 2024 | 10.18 | -1.17 |
Guard Therapeutics International | GUARD | Nov 15, 2024 | 20.80 | -1.89 |
Guideline Geo | GGEO | Nov 15, 2024 | 7.96 | +0.76 |
Gullberg & Jansson | GJAB | Nov 15, 2024 | 16.00 | -6.43 |
H&D Wireless Sweden Holding B | HDWB | Nov 15, 2024 | 0.00 | +11.11 |
H&M B | HMB | Nov 15, 2024 | 155.70 | +0.45 |
HAKI Safety A | HAKIA | Nov 15, 2024 | 27.00 | 0.00 |
HAKI Safety B | HAKIB | Nov 15, 2024 | 25.40 | -5.58 |
Hamlet BioPharma AB (publ) | HAMLETB | Nov 15, 2024 | 2.86 | +1.78 |
Hansa Biopharma | HNSA | Nov 15, 2024 | 31.70 | -4.00 |
Hanza AB | HANZA | Nov 15, 2024 | 69.85 | -1.69 |
Harm Reduction Group | NOHARM | Nov 15, 2024 | 0.05 | -9.67 |
Havsfrun Investment | HAVS | Nov 15, 2024 | 12.50 | -0.79 |
Havsfrun Investment B | HAVB | Nov 15, 2024 | 12.50 | -0.79 |
Haypp Group | HAYPP | Nov 15, 2024 | 60.20 | +1.69 |
Headsent | VIMAB | Nov 15, 2024 | 9.75 | +1.56 |
Heba B | HEBAB | Nov 15, 2024 | 32.35 | -1.82 |
Hedera Group | HEGR | Nov 15, 2024 | 2.70 | -6.90 |
Heimstaden Pref | HEIMPREF | Nov 15, 2024 | 15.20 | +0.66 |
Heliospectra | HELIO | Nov 15, 2024 | 0.44 | -1.35 |
Hemnet Group | HEM | Nov 15, 2024 | 326.20 | -0.97 |
Hemply Balance | HMPLY | Nov 15, 2024 | 0.04 | -2.38 |
Hernö Gin B | HERNOB | Nov 15, 2024 | 3.90 | 0.00 |
Hexagon B | HEXAB | Nov 15, 2024 | 94.02 | -1.86 |
Hexagon Purus | HPURO | Nov 15, 2024 | 5.67 | +9.04 |
Hexatronic Group | HTRO | Nov 15, 2024 | 38.12 | -4.51 |
Hexicon | HEXI | Nov 15, 2024 | 0.18 | +2.13 |
Hexpol B | HPOLB | Nov 15, 2024 | 103.80 | -0.48 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.